Sphingosine kinase inhibitors
Patent Information
- Authority / Receiving Office
- CN Ā· China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- MERCK PATENT GMBH
- Publication Date
- 2014-07-23
- Estimated Expiration
- Not applicable Ā· inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to sphingosine kinase inhibitors and physiologically acceptable salts, derivatives, prodrugs, solvates, tautomers and stereoisomers thereof for use in the treatment of diseases affected by the inhibition of Sph kinase 1, including mixtures in all their proportions. Background of the invention
[0002] The object of the present invention was to discover new compounds having valuable properties, in particular those which can be used for the preparation of medicaments.
[0003] The present invention relates to compounds and the use of these compounds for the treatment of diseases associated with elevated levels of sphingosine phosphate, and to pharmaceutical compositions comprising these compounds.
[0004] In particular, the present invention relates to compounds of formula (I), which preferably inhibit the enzyme sphingosine kinase 1, which regulates sphingosine phosphate levels through the phosphorylation of sphingosine, ...